nimodipine has been researched along with Intracranial Arteriosclerosis in 3 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Intracranial Arteriosclerosis: Vascular diseases characterized by thickening and hardening of the walls of ARTERIES inside the SKULL. There are three subtypes: (1) atherosclerosis with fatty deposits in the ARTERIAL INTIMA; (2) Monckeberg's sclerosis with calcium deposits in the media and (3) arteriolosclerosis involving the small caliber arteries. Clinical signs include HEADACHE; CONFUSION; transient blindness (AMAUROSIS FUGAX); speech impairment; and HEMIPARESIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, WJ | 1 |
| Du, B | 1 |
| Leung, TW | 1 |
| Xu, XT | 1 |
| Jin, M | 1 |
| Dong, KH | 1 |
| Alekhin, MN | 1 |
| Sedov, VP | 1 |
| Botsina, GI | 1 |
| Sidorenko, BA | 1 |
| Nosenko, EM | 1 |
| Otomo, E | 1 |
3 other studies available for nimodipine and Intracranial Arteriosclerosis
| Article | Year |
|---|---|
Symptomatic intracranial stenosis: cerebrovascular complications from elective stent placement.
Topics: Adolescent; Adult; Aged; Angioplasty, Balloon; Cerebral Hemorrhage; Female; Humans; Intracranial Art | 2007 |
[Effect of nimodipine in the diastolic function of the left ventricle in patients with essential hypertension and atherosclerotic circulatory encephalopathy].
Topics: Administration, Oral; Aged; Calcium Channel Blockers; Diastole; Female; Hemodynamics; Humans; Hypert | 1996 |
[Nervous disease & Ca antagonist].
Topics: Calcium Channel Blockers; Cerebral Infarction; Cerebrovascular Disorders; Epilepsy; Flunarizine; Hum | 1990 |